Delivery Order SPE2DR25D3202-SPE2DR26F8E3D
- Not listed
- The Defense Logistics Agency awarded a $2,670.99 delivery order to AmerisourceBergen Drug Corp for NORA-BE Tablet 28S pharmaceutical products on September 26, 2025, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,326.31 to AmerisourceBergen Drug Corp for NORA-BE Tablet 28S on October 20, 2025, with completion expected by October 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,287.74 by the Defense Logistics Agency (DLA) on December 16, 2025, for the supply of Nora-BE Tablet 28S. This competitively awarded, firm fixed-price delivery order is expected to be completed by December 17, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract utilized no...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $26,954.56 delivery order to AmerisourceBergen Drug Corp for ORSERDU 345 mg tablets (30-count supply) on December 8, 2025, with completion scheduled for December 30, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $15,967.36 to AmerisourceBergen Drug Corp on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order calls for pharmaceutical products and medical supplies to support federal healthcare operations,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,080.31 by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order valued at $26,087.82 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 19, 2025, was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $247,197.12 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025. This firm fixed-price delivery order, with completion scheduled for September 30, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E3DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,058.79 to AmerisourceBergen Drug Corp for NORA-BE TABLET 28S on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a major healthcare solutions provider, the company supplies a comprehensive range of pharmaceutical products and medical supplies through its DLA prime vendor agreement, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The smaller transaction size of this particular order is consistent with AmerisourceBergen's demonstrated versatility in fulfilling federal medical supply needs across the broad spectrum of its pharmaceutical portfolio, from routine medications to specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/1/26 |